Dexketoprofen trometamol quick-release/sustained-release double-layer tablet and preparation method thereof

A technology of dexketoprofen trometamol and double-layer tablets, which is applied in the field of medicine and can solve the problems of low blood drug concentration, inability to rapidly release drug active ingredients, and short half-life.

Active Publication Date: 2014-03-26
GUIYANG MEDICAL UNIVERSITY
View PDF2 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] But clinically existing dexketoprofen trometamol preparations have a short half-life, common dosage forms need to be taken three to four times a day, and the blood drug concentration fluctuates greatly, while its sustained-release preparations release slowly and cannot rapidly release drug activity. composition, so that the maximum blood concentration is lower; and the dexketoprofen trometamol in the quick-release layer after oral administration of the double-layer sustained-release preparation developed by us dissolves quickly and relieves symptoms quickly, and the sustained-release layer then releases slowly, so that The analgesic and anti-inflammatory effect lasts for 12 hours, reduces the number of medications, improves patient compliance, and reduces adverse reactions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dexketoprofen trometamol quick-release/sustained-release double-layer tablet and preparation method thereof
  • Dexketoprofen trometamol quick-release/sustained-release double-layer tablet and preparation method thereof
  • Dexketoprofen trometamol quick-release/sustained-release double-layer tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0051] Prescription (according to 1000 tablets)

[0052] Immediate release layer:

[0053]

[0054] Slow release layer:

[0055]

[0056]

[0057] In pharmaceutical preparations, the influence of the main drug and the excipients is mutual. Simply put, the characteristics of the main drug determine the choice of excipients, and the characteristics of the excipients determine the efficacy of the main drug. This mutual influence relationship has always existed in the whole process from the research of pharmaceutical preparations to clinical use.

[0058] The following experiments show that the present invention selects the auxiliary materials suitable for the purpose of the present invention, determines the dosage of each component of the tablet, and improves the process of the production process through various experiments on the auxiliary materials.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a dexketoprofen trometamol quick-release / sustained-release double-layer tablet and a preparation method thereof, and provides a simple and convenient preparation process method for pressing the double-layer tablet consisting of a quick-release layer and a sustained-release layer, wherein the quick-release layer mainly comprises dexketoprofen trometamol, a sustained-release, a diluent, a binding agent and a lubricant. According to the dexketoprofen trometamol quick-release / sustained-release double-layer tablet provided by the invention, due to release of the quick-release part, the medicine is enabled to rapidly achieve effective blood concentration, the sustained-release part can be released slowly, and the effect that the dexketoprofen trometamol can be continuously released for 12 hours when being taken once is achieved. The defects that the conventional dexketoprofen trometamol preparation needs to be taken for multiple times in clinical treatment, and the blood concentration is not stable are made up, so that the effects of improving compliance of patients, stable curative effect and small toxic and side effects are achieved. The tablet is simple in preparation method, raw materials and auxiliaries can be easily obtained, and the tablet is applicable to industrial production and has a good application prospect.

Description

technical field [0001] The present invention relates to a new type of pharmaceutical preparation in the category of non-steroidal anti-inflammatory pharmaceutical preparations, in particular to the preparation process of dexketoprofen trometamol quick-release sustained-release double-layer tablet, which is characterized in that it consists of an immediate-release layer and The invention relates to a double-layer tablet made by co-compressing sustained-release layers, which belongs to the field of medicine. Background technique [0002] A double-layer sustained-release tablet is a tablet dosage form in which one or two drugs are made into two parts, an immediate-release layer and a sustained-release layer. The immediate-release layer and the sustained-release layer can be the same drug, or two drugs with synergistic effects. The quick-release layer can quickly relieve or treat the disease in a short period of time, reducing the harm to the patient caused by the onset of the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/24A61K31/192A61P29/00
Inventor 黄勇王永林石凌云郑林何峰兰燕宇李勇军王爱民廖尚高傅晓钟周雯张治蓉陈慧
Owner GUIYANG MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products